Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Agnelli

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Cancers|March 29, 2020
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple MyelomaDomenica Ronchetti, Katia Todoerti, Cristina Vinci, et al.
Scientific Reports|May 13, 2023
Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinomaJacopo Azzollini, Luca Agnelli, Elena Conca, et al.
Oncotarget|October 27, 2015
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patientsEnrica Calura, Andrea Bisognin, Martina Manzoni, et al.
Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practiceAndrea Vingiani, Daniele Lorenzini, Elena Conca, et al.
Journal of Cellular and Molecular Medicine|April 3, 2026
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple MyelomaDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Tumori|July 9, 2025
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridizationDaniele Lorenzini, Rebecca Salvatori, Chiara Costanza Volpi, et al.
Oncotarget|June 20, 2015
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activationMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
British Journal of Haematology|May 31, 2013
Improved risk stratification in myeloma using a microRNA-based classifierPing Wu, Luca Agnelli, Brian A Walker, et al.
Genes, Chromosomes & Cancer|December 19, 2013
Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemiaDomenica Ronchetti, Giacomo Tuana, Andrea Rinaldi, et al.
Oncogene|March 1, 2005
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myelomaMichela Mattioli, Luca Agnelli, Sonia Fabris, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Cancers|March 29, 2020
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple MyelomaDomenica Ronchetti, Katia Todoerti, Cristina Vinci, et al.
Scientific Reports|May 13, 2023
Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinomaJacopo Azzollini, Luca Agnelli, Elena Conca, et al.
Oncotarget|October 27, 2015
Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patientsEnrica Calura, Andrea Bisognin, Martina Manzoni, et al.
Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practiceAndrea Vingiani, Daniele Lorenzini, Elena Conca, et al.
Journal of Cellular and Molecular Medicine|April 3, 2026
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple MyelomaDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Tumori|July 9, 2025
Validating HER2 copy number variation assessment by NGS: A comparative analysis with immunohistochemistry and in situ hybridizationDaniele Lorenzini, Rebecca Salvatori, Chiara Costanza Volpi, et al.
Oncotarget|June 20, 2015
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activationMarta Lionetti, Marzia Barbieri, Katia Todoerti, et al.
British Journal of Haematology|May 31, 2013
Improved risk stratification in myeloma using a microRNA-based classifierPing Wu, Luca Agnelli, Brian A Walker, et al.
Genes, Chromosomes & Cancer|December 19, 2013
Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemiaDomenica Ronchetti, Giacomo Tuana, Andrea Rinaldi, et al.
Oncogene|March 1, 2005
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myelomaMichela Mattioli, Luca Agnelli, Sonia Fabris, et al.
Pageof 12